Cargando…

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness

Mostrar otras versiones (1)

The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person’s infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop viral dynamic models of SARS-CoV-2 infection and fit them to data t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Ruian, Zitzmann, Carolin, Ho, David D., Ribeiro, Ruy M., Perelson, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670484/ https://www.ncbi.nlm.nih.gov/pubmed/34857628 http://dx.doi.org/10.1073/pnas.2111477118

Ejemplares similares

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
por: Ke, Ruian, et al.
Publicado: (2021)

Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir
por: Kumar, Mithra R., et al.
Publicado: (2023)

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
por: Phan, Tin, et al.
Publicado: (2023)

An explanation for SARS-CoV-2 rebound after Paxlovid treatment
por: Perelson, Alan S., et al.
Publicado: (2023)

A simple model of COVID-19 explains disease severity and the effect of treatments
por: Sanche, Steven, et al.
Publicado: (2022)

Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release
por: Zitzmann, Carolin, et al.
Publicado: (2020)

Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells
por: Ke, Ruian, et al.
Publicado: (2015)

Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA
por: Lau, Max S. Y., et al.
Publicado: (2020)

Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti–HIV-1 IgG1 antibodies in vivo
por: Wang, Pengfei, et al.
Publicado: (2020)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
por: Néant, Nadège, et al.
Publicado: (2021)

Modeling the within-host dynamics of HIV infection
por: Perelson, Alan S, et al.
Publicado: (2013)

Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
por: White, Jennifer A., et al.
Publicado: (2022)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

Kinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae
por: Smith, Amber M., et al.
Publicado: (2013)

Kinetic profiling of metabolic specialists demonstrates stability and consistency of in vivo enzyme turnover numbers
por: Heckmann, David, et al.
Publicado: (2020)

Prolonged viral shedding from noninfectious individuals confounds wastewater-based epidemiology
por: Phan, Tin, et al.
Publicado: (2023)

The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans
por: Goyal, Ashish, et al.
Publicado: (2017)

An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo
por: Liu, Kuo, et al.
Publicado: (2023)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants
por: Despres, Hannah W., et al.
Publicado: (2022)

Antibody Responses during Hepatitis B Viral Infection
por: Ciupe, Stanca M., et al.
Publicado: (2014)

Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2022)

Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods
por: Viloria Winnett, Alexander, et al.
Publicado: (2023)

A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection
por: Zitzmann, Carolin, et al.
Publicado: (2020)

Effect of 1918 PB1-F2 Expression on Influenza A Virus Infection Kinetics
por: Smith, Amber M., et al.
Publicado: (2011)

Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence
por: Ke, Ruian, et al.
Publicado: (2018)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs
por: Pan, Ke, et al.
Publicado: (2021)

Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues
por: De Boer, Rob J., et al.
Publicado: (2010)

Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4(+) T cells
por: Sambaturu, Narmada, et al.
Publicado: (2023)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

Inhalable nanocatchers for SARS-CoV-2 inhibition
por: Zhang, Han, et al.
Publicado: (2021)

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022)

Accelerated Immunodeficiency by Anti-CCR5 Treatment in HIV Infection
por: Weinberger, Ariel D., et al.
Publicado: (2009)

Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
por: Vaidya, Naveen K., et al.
Publicado: (2016)

Restriction of SARS-CoV-2 replication by targeting programmed −1 ribosomal frameshifting
por: Sun, Yu, et al.
Publicado: (2021)

Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
por: Nair, Manoj S., et al.
Publicado: (2023)

In vivo single-molecule kinetics of activation and subsequent activity of the arabinose promoter
por: Mäkelä, Jarno, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2vs6n87a7k8pfn77nt2b5gqqln